Remove Containment Remove Contamination Remove Vaccination
article thumbnail

BioNTech Unveils the BioNTainer, a Modular mRNA Vaccine Factory to Help Production in Africa

XTalks

BioNTech announced its new vaccine manufacturing approach in Africa where the company will ship modular factories, called the BioNTainer, to the continent to enable domestic production of the vaccines to help increase supplies. Related: BioNTech to Build First mRNA Vaccine Production Plant in Africa. Photo source: BioNTech.

article thumbnail

STAT+: Pharmalittle: Moderna must face patent claims over its Covid-19 vaccine; Pfizer and BioNTech testing combo Covid and flu shot

STAT News

… A Delaware federal court refused to throw out patent infringement claims brought by Arbutus Biopharma and Genevant Sciences against Moderna over its sale of Covid-19 vaccine doses to the U.S.  Genevant and Arbutus sued Moderna in February, seeking royalties from Moderna’s sale of its Covid-19 vaccine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa

The Pharma Data

BioNTech SE (Nasdaq: BNTX, “BioNTech”) has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution.

article thumbnail

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

Section 351 of the Public Health Service (PHS) Act defines a biological product as a “virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product. Essentially, a biologic is a product that is produced from living organisms or that contains components of living organisms.

article thumbnail

Black Women’s Group Launches Lawsuit Against Johnson & Johnson Over Targeted Baby Powder Ads

XTalks

Johnson and Johnson has faced thousands of lawsuits over its iconic baby powder, which people claim the company knew for decades contained asbestos. Talc and asbestos are often found together in nature, which is why mined talc can contain the carcinogen. Related: AstraZeneca Prevails in EU COVID-19 Vaccine Lawsuit. “We

article thumbnail

Optimizing lyophilization cycle times and improving stability for complex injectables 

Pharmaceutical Technology

PM: Lyophilization is widely used in the pharmaceutical and biotech industry for small molecule drug products, vaccines, antibodies, and other biological material. KB: Some formulations contain low concentrations of the active ingredient. What are the key advantages of this stabilization method? Free eBook. United Kingdom. Afghanistan.

article thumbnail

Quality by design with a focus on biosimilars

Pharmaceutical Technology

For companies in the US, if the results show bioequivalence, an abbreviated new drug application (ANDA) containing the results is sent to the FDA to review and potentially approve. Even minor amounts of biological contaminants in your sample could cause unwanted biological effects,” Dr Amiji says.